EXHIBIT 3. Five safety-net public health care systems’ performance on warfarin monitoring and timely follow-up of abnormal international normalized ratio (INR) in years 1 and 2 of their participation in the California Public Hospital Redesign and Incentives in Medi-Cal (PRIME) Program.
SOURCE Authors’ analysis of data provided by the California Department of Health Care Services. NOTES Year 1 was July 1, 2015–June 30, 2016, and year 2 was July 1, 2016–June 30, 2017. These optional measures were reported by only these five systems. Systems A, B, and I used comprehensive electronic health record systems. Percentages were determined as described in the notes to exhibit 2. System P reported a divergent change from year 1 to year 2 for follow-up of abnormal INR; see the text for details.